Traditional inactivated flu vaccines are often poorly immunogenic in the elderly. Adjuvantation with MF59 may increase vaccine effectiveness among seniors. The aim was to assess MF59-vaccine effectiveness in preventing influenza-related outcomes. Our review suggests that MF59-adjuvanted vaccine is highly effective in the elderly. Field effectiveness of MF59-adjuvanted vaccine is superior to unadjuvanted vaccines.